三位视觉科学公司的高管在2026年4月1日和2日出售了147,243美元的股票. Three Sight Sciences executives sold $147,243 in stock on April 1 and 2, 2026.

2026年4月1日和2日,视觉科学公司的三名高管共售出147,243美元的股票. On April 1 and 2, 2026, three executives at Sight Sciences sold a total of $147,243 in stock. 首席执行官保罗·巴达维卖出了108,202美元,副总裁布伦顿·泰勒卖出10,615美元,而技术总监大卫·巴達維则卖出28424美元. CEO Paul Badawi sold $108,202, EVP Brenton Taylor sold $10,615, and CTO David Badawi sold $28,424. 公司报告季度亏损, 但略高于预期收入. The company, which makes medical devices for eye conditions, reported a quarterly loss but slightly exceeded revenue expectations. 股票交易价格为3.52美元, 持有评级. The stock trades at $3.52 with a consensus "Hold" rating.